Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 269

1.

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal.

Del Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli GB.

Diabet Med. 1998 Jul;15(7):592-600.

PMID:
9686700
[PubMed - indexed for MEDLINE]
2.

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB.

Diabetes Care. 1999 Mar;22(3):468-77.

PMID:
10097931
[PubMed - indexed for MEDLINE]
Free Article
3.

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.

Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.

Diabet Med. 2004 Nov;21(11):1213-20.

PMID:
15498088
[PubMed - indexed for MEDLINE]
4.

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.

Jacober SJ, Scism-Bacon JL, Zagar AJ.

Diabetes Obes Metab. 2006 Jul;8(4):448-55.

PMID:
16776752
[PubMed - indexed for MEDLINE]
5.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
[PubMed - indexed for MEDLINE]
6.

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

Diabetes Care. 2003 May;26(5):1490-6.

PMID:
12716810
[PubMed - indexed for MEDLINE]
7.
8.

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

Ciofetta M, Lalli C, Del Sindaco P, Torlone E, Pampanelli S, Mauro L, Chiara DL, Brunetti P, Bolli GB.

Diabetes Care. 1999 May;22(5):795-800.

PMID:
10332684
[PubMed - indexed for MEDLINE]
Free Article
9.

Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections.

Colombel A, Murat A, Krempf M, Kuchly-Anton B, Charbonnel B.

Diabet Med. 1999 Apr;16(4):319-24.

PMID:
10220206
[PubMed - indexed for MEDLINE]
10.

Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes.

Valle D, Santoro D, Bates P, Scarpa L; Italian Multicentre Lispro Study Group.

Diabetes Nutr Metab. 2001 Jun;14(3):126-32.

PMID:
11476359
[PubMed - indexed for MEDLINE]
11.
12.

Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control and hypoglycaemia.

Rönnemaa T, Viikari J.

Diabet Med. 1998 Jul;15(7):601-7.

PMID:
9686701
[PubMed - indexed for MEDLINE]
13.
15.

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

Pfützner A, Küstner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J.

Exp Clin Endocrinol Diabetes. 1996;104(1):25-30.

PMID:
8750567
[PubMed - indexed for MEDLINE]
16.

Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.

Ahmed AB, Mallias J, Home PD.

Diabetes Care. 1998 Jul;21(7):1162-6.

PMID:
9653613
[PubMed - indexed for MEDLINE]
17.

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD.

Diabet Med. 2006 Mar;23(3):285-92.

PMID:
16492212
[PubMed - indexed for MEDLINE]
18.

Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.

Sargin H, Sargin M, Altuntaş Y, Sengül AM, Orbay E, Seber S, Uçak S, Yayla A.

Diabetes Res Clin Pract. 2003 Nov;62(2):79-86.

PMID:
14581144
[PubMed - indexed for MEDLINE]
19.

Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?

Heller SR, Amiel SA, Evans ML, Kong MF, Macdonald IA, Peacey SR.

Diabetes Obes Metab. 2002 Mar;4(2):106-12.

PMID:
11940107
[PubMed - indexed for MEDLINE]
20.

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.

Heller SR, Amiel SA, Mansell P.

Diabetes Care. 1999 Oct;22(10):1607-11.

PMID:
10526722
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk